Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China · Delayed Price · Currency is CNY 6.80
+0.16 (2.41%)
Feb 4, 2026, 3:00 PM CST
Hainan Huluwa Pharmaceutical Group Company Description
Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of Children's digestive system, respiratory system, anti-infection, anti-virus and other fields in China.
The company offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products.
Hainan Huluwa Pharmaceutical Group Co., Ltd. was founded in 2005 and is based in Haikou, China.
Hainan Huluwa Pharmaceutical Group Co., Ltd.
| Country | China |
| Founded | 2005 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,103 |
| CEO | Jinping Liu |
Contact Details
Address: No. 30, Anyu 1st Road Haikou, 571157 China | |
| Phone | 86 898 6861 2158 |
| Website | huluwayaoye.com |
Stock Details
| Ticker Symbol | 605199 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100004223 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jinping Liu | GM and Chairman of the Board |
| Hui Yu | Financial Director, Deputy GM and Director |
| Qingtao Wang | Secretary |
| Tianbao Wei | Deputy General Manager |
| Wei Li | Accounting Supervisor |
| Jun Ling Li | Deputy GM and Director |
| Pei Hu Li | Deputy General Manager |